← Back to headlines
AbbVie Presents Data on Venetoclax-Based Combination Therapy
AbbVie Inc. (ABBV) presented new data on its fixed-duration venetoclax-based combination therapy, advancing its research in medical treatments.
17 Jun, 17:34 — 17 Jun, 17:34
Sources
Showing 1 of 1 sources
Related Stories
Volkswagen Approves Major Restructuring Plan Targeting 100,000 Jobs
23m ago
Trump Administration Seeks Supreme Court Approval for Mail Ballot Restrictions
45m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
46m ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
51m ago